EU to fine Ranbaxy for blocking generic drugs
Updated on Jun 04, 2013 06:39 pm IST
Clamping down on "pay-for-delay" deals in the pharmaceutical sector, a European regulator will fine Denmark's Lundbeck, India's Ranbaxy and seven other makers of generic drugs this month for limiting the supply of cheaper medicines to the market.
RELATED VIDEOS
'Americans preoccupied with other matters': Russia ridicules Trump
Published on Jul 16, 2026 08:50 am IST
American arrested near India-Nepal border had China passport
Published on Jul 15, 2026 02:00 pm IST
Ukraine's biggest backer left embarrassed; Merz booed
Published on Jul 15, 2026 01:57 pm IST
Bibi's hawkish minister says ‘we are winning’, defends bombing Gaza
Published on Jul 15, 2026 01:52 pm IST
How walkable is Delhi? Even rare patches of footpaths unusable in NFC
Published on Jul 10, 2026 09:05 pm IST
Indian ex-Envoy who was recalled over Nijjar case reacts to Canada's u-turn
Published on Jul 10, 2026 03:59 pm IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}